Theo Clyde Manschreck, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 51 | 2023 | 6874 | 1.930 |
Why?
|
| Schizophrenic Psychology | 36 | 2016 | 1677 | 1.630 |
Why?
|
| Antipsychotic Agents | 20 | 2023 | 3058 | 1.100 |
Why?
|
| Psychomotor Disorders | 4 | 2015 | 152 | 0.940 |
Why?
|
| Schizotypal Personality Disorder | 3 | 2010 | 288 | 0.840 |
Why?
|
| Association | 4 | 2012 | 53 | 0.760 |
Why?
|
| Psychotic Disorders | 12 | 2023 | 3040 | 0.660 |
Why?
|
| Family Health | 2 | 2015 | 1282 | 0.660 |
Why?
|
| Marijuana Abuse | 2 | 2018 | 402 | 0.560 |
Why?
|
| Schizophrenic Language | 11 | 1991 | 69 | 0.440 |
Why?
|
| Speech Disorders | 1 | 2012 | 189 | 0.390 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2013 | 503 | 0.350 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1150 | 0.350 |
Why?
|
| Endophenotypes | 1 | 2010 | 250 | 0.330 |
Why?
|
| Psychiatric Status Rating Scales | 22 | 2017 | 6030 | 0.320 |
Why?
|
| Motivation | 1 | 2018 | 1968 | 0.320 |
Why?
|
| Clozapine | 5 | 2007 | 498 | 0.310 |
Why?
|
| Electroconvulsive Therapy | 1 | 2013 | 472 | 0.310 |
Why?
|
| Neuropsychological Tests | 20 | 2016 | 6974 | 0.300 |
Why?
|
| Schizophrenia, Paranoid | 4 | 2006 | 104 | 0.300 |
Why?
|
| Cognition Disorders | 12 | 2016 | 4030 | 0.290 |
Why?
|
| Verbal Behavior | 2 | 2007 | 339 | 0.290 |
Why?
|
| Functional Laterality | 6 | 2015 | 2290 | 0.290 |
Why?
|
| Individuality | 1 | 2007 | 303 | 0.260 |
Why?
|
| Psychology, Clinical | 1 | 2005 | 42 | 0.260 |
Why?
|
| Psychomotor Performance | 6 | 2010 | 1895 | 0.250 |
Why?
|
| Risperidone | 4 | 2016 | 383 | 0.250 |
Why?
|
| Mental Recall | 7 | 2013 | 1205 | 0.240 |
Why?
|
| Motor Activity | 4 | 2016 | 2714 | 0.240 |
Why?
|
| Cocaine | 4 | 1993 | 1008 | 0.240 |
Why?
|
| Thinking | 11 | 2005 | 319 | 0.240 |
Why?
|
| Paranoid Disorders | 3 | 1996 | 60 | 0.220 |
Why?
|
| Psychopathology | 1 | 2005 | 402 | 0.220 |
Why?
|
| Neurologic Examination | 4 | 2010 | 931 | 0.210 |
Why?
|
| Movement Disorders | 5 | 1997 | 444 | 0.210 |
Why?
|
| Executive Function | 2 | 2013 | 1362 | 0.210 |
Why?
|
| Social Alienation | 1 | 2000 | 19 | 0.180 |
Why?
|
| Mentally Ill Persons | 1 | 2001 | 126 | 0.180 |
Why?
|
| Verbal Learning | 2 | 2000 | 466 | 0.180 |
Why?
|
| Speech | 6 | 1991 | 540 | 0.180 |
Why?
|
| Models, Psychological | 2 | 2018 | 810 | 0.170 |
Why?
|
| Child Development | 1 | 2010 | 2222 | 0.160 |
Why?
|
| Memory Disorders | 2 | 2013 | 1183 | 0.160 |
Why?
|
| Adult | 68 | 2018 | 213712 | 0.160 |
Why?
|
| Delusions | 3 | 1996 | 300 | 0.160 |
Why?
|
| Psychoses, Substance-Induced | 2 | 1988 | 96 | 0.150 |
Why?
|
| Neurology | 1 | 2005 | 762 | 0.150 |
Why?
|
| Research | 1 | 2005 | 1999 | 0.140 |
Why?
|
| Placebos | 2 | 2001 | 1677 | 0.140 |
Why?
|
| Male | 68 | 2018 | 349538 | 0.140 |
Why?
|
| Reaction Time | 5 | 2016 | 2092 | 0.130 |
Why?
|
| Thiazoles | 2 | 2013 | 1484 | 0.130 |
Why?
|
| Affective Disorders, Psychotic | 3 | 2013 | 191 | 0.130 |
Why?
|
| Receptors, Dopamine | 1 | 2016 | 294 | 0.130 |
Why?
|
| Dopamine Antagonists | 1 | 2016 | 296 | 0.130 |
Why?
|
| Analysis of Variance | 4 | 2013 | 6365 | 0.130 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 4929 | 0.130 |
Why?
|
| Word Association Tests | 2 | 2012 | 57 | 0.130 |
Why?
|
| Humans | 94 | 2023 | 742088 | 0.120 |
Why?
|
| Female | 61 | 2018 | 379592 | 0.120 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2010 | 3649 | 0.120 |
Why?
|
| Cognition | 5 | 2007 | 6722 | 0.120 |
Why?
|
| Sulpiride | 1 | 2013 | 17 | 0.110 |
Why?
|
| Substance-Related Disorders | 4 | 1993 | 4250 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2017 | 604 | 0.110 |
Why?
|
| Reality Testing | 2 | 2007 | 26 | 0.110 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2013 | 150 | 0.110 |
Why?
|
| Psychometrics | 3 | 2010 | 2999 | 0.110 |
Why?
|
| Mental Competency | 2 | 2011 | 176 | 0.110 |
Why?
|
| Piperazines | 2 | 2013 | 2488 | 0.110 |
Why?
|
| Semantics | 4 | 2013 | 584 | 0.110 |
Why?
|
| Evoked Potentials | 2 | 2016 | 1057 | 0.110 |
Why?
|
| Risk | 3 | 2015 | 9679 | 0.110 |
Why?
|
| Memory | 3 | 2006 | 2163 | 0.100 |
Why?
|
| Writing | 2 | 1987 | 205 | 0.100 |
Why?
|
| Attention | 6 | 2013 | 2396 | 0.100 |
Why?
|
| Adolescent | 15 | 2018 | 85649 | 0.100 |
Why?
|
| Language | 2 | 2013 | 1458 | 0.100 |
Why?
|
| Electroencephalography | 4 | 2016 | 6142 | 0.100 |
Why?
|
| Research Design | 3 | 2007 | 5979 | 0.090 |
Why?
|
| Clinical Trials as Topic | 5 | 2007 | 7901 | 0.090 |
Why?
|
| Informed Consent | 2 | 2011 | 991 | 0.090 |
Why?
|
| Hospitals, Psychiatric | 2 | 1999 | 332 | 0.090 |
Why?
|
| Young Adult | 7 | 2018 | 56350 | 0.090 |
Why?
|
| Quinolones | 1 | 2013 | 366 | 0.090 |
Why?
|
| Mood Disorders | 3 | 1992 | 1106 | 0.090 |
Why?
|
| Benzodiazepines | 2 | 2013 | 1101 | 0.080 |
Why?
|
| Dopamine | 1 | 2016 | 1589 | 0.080 |
Why?
|
| Object Attachment | 1 | 1991 | 313 | 0.080 |
Why?
|
| Depressive Disorder | 7 | 2006 | 3748 | 0.080 |
Why?
|
| Personality Inventory | 1 | 2010 | 1026 | 0.080 |
Why?
|
| Frontal Lobe | 3 | 2000 | 1407 | 0.070 |
Why?
|
| Patient Admission | 1 | 1994 | 1380 | 0.070 |
Why?
|
| Schizophrenia, Disorganized | 1 | 1986 | 11 | 0.070 |
Why?
|
| Dioxoles | 1 | 2007 | 104 | 0.070 |
Why?
|
| Albinism | 1 | 1986 | 25 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2013 | 1459 | 0.070 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 15530 | 0.070 |
Why?
|
| Mental Status Schedule | 2 | 1990 | 321 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8621 | 0.070 |
Why?
|
| Reference Values | 2 | 2012 | 4982 | 0.070 |
Why?
|
| Recurrence | 4 | 2023 | 8333 | 0.070 |
Why?
|
| Administration, Oral | 3 | 2016 | 3913 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2007 | 10943 | 0.070 |
Why?
|
| Brain Mapping | 4 | 2013 | 6669 | 0.060 |
Why?
|
| Minnesota | 1 | 2005 | 343 | 0.060 |
Why?
|
| Patient Readmission | 2 | 2016 | 3111 | 0.060 |
Why?
|
| Brain | 5 | 2016 | 26343 | 0.060 |
Why?
|
| Hospitals, State | 1 | 1984 | 29 | 0.060 |
Why?
|
| Language Disorders | 1 | 2005 | 140 | 0.060 |
Why?
|
| Mental Disorders | 5 | 1989 | 6587 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 1992 | 1827 | 0.060 |
Why?
|
| Community Mental Health Centers | 1 | 1984 | 102 | 0.060 |
Why?
|
| Periodicity | 1 | 2005 | 363 | 0.060 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1984 | 135 | 0.060 |
Why?
|
| China | 1 | 2010 | 2246 | 0.060 |
Why?
|
| Stuttering | 2 | 1980 | 25 | 0.060 |
Why?
|
| Middle Aged | 36 | 2017 | 213127 | 0.060 |
Why?
|
| Biofeedback, Psychology | 3 | 1980 | 115 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 6483 | 0.060 |
Why?
|
| Hospitals, Public | 1 | 1984 | 207 | 0.050 |
Why?
|
| Phenotype | 2 | 2012 | 16331 | 0.050 |
Why?
|
| Injections | 2 | 2016 | 840 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 719 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1988 | 2231 | 0.050 |
Why?
|
| Agranulocytosis | 1 | 2001 | 100 | 0.050 |
Why?
|
| HIV Seropositivity | 1 | 1988 | 970 | 0.050 |
Why?
|
| Motor Skills | 2 | 1984 | 518 | 0.050 |
Why?
|
| Delayed-Action Preparations | 2 | 2016 | 965 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2012 | 3493 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2009 | 1771 | 0.050 |
Why?
|
| Raynaud Disease | 2 | 1979 | 67 | 0.050 |
Why?
|
| Demography | 1 | 2006 | 1650 | 0.050 |
Why?
|
| Control Groups | 1 | 2001 | 105 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2007 | 6452 | 0.050 |
Why?
|
| Hospitalization | 3 | 2012 | 10232 | 0.050 |
Why?
|
| Visual Perception | 3 | 2016 | 1417 | 0.040 |
Why?
|
| Decision Making | 3 | 2013 | 3869 | 0.040 |
Why?
|
| Paired-Associate Learning | 2 | 1996 | 52 | 0.040 |
Why?
|
| Psychoanalytic Theory | 2 | 1995 | 143 | 0.040 |
Why?
|
| Age of Onset | 3 | 2012 | 3266 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13256 | 0.040 |
Why?
|
| Dyskinesia, Drug-Induced | 2 | 1994 | 164 | 0.040 |
Why?
|
| Time Factors | 7 | 2016 | 40054 | 0.040 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 1999 | 108 | 0.040 |
Why?
|
| Piperidines | 1 | 2007 | 1602 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 1993 | 633 | 0.040 |
Why?
|
| Brain Diseases | 1 | 1988 | 1554 | 0.040 |
Why?
|
| Bahamas | 2 | 1988 | 11 | 0.040 |
Why?
|
| Bipolar Disorder | 4 | 2013 | 5024 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 647 | 0.040 |
Why?
|
| Handwriting | 1 | 1997 | 28 | 0.040 |
Why?
|
| Psychiatry | 2 | 2001 | 1695 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2005 | 2739 | 0.040 |
Why?
|
| Prevalence | 2 | 2010 | 15194 | 0.040 |
Why?
|
| Memory, Short-Term | 2 | 2013 | 972 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2016 | 35342 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1953 | 0.040 |
Why?
|
| Chronic Disease | 4 | 1999 | 9144 | 0.040 |
Why?
|
| Perceptual Disorders | 1 | 1998 | 196 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2010 | 21719 | 0.030 |
Why?
|
| Age Factors | 3 | 2004 | 18355 | 0.030 |
Why?
|
| Lithium | 3 | 2001 | 601 | 0.030 |
Why?
|
| Brain Injuries | 1 | 1988 | 2024 | 0.030 |
Why?
|
| Behavior Therapy | 2 | 1979 | 866 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2006 | 2680 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 1978 | 651 | 0.030 |
Why?
|
| Logistic Models | 1 | 2010 | 13403 | 0.030 |
Why?
|
| Electromagnetic Fields | 1 | 2016 | 298 | 0.030 |
Why?
|
| Fingers | 2 | 2016 | 514 | 0.030 |
Why?
|
| Activities of Daily Living | 2 | 1994 | 2414 | 0.030 |
Why?
|
| Interview, Psychological | 2 | 2012 | 812 | 0.030 |
Why?
|
| Internal-External Control | 1 | 1995 | 363 | 0.030 |
Why?
|
| Language Tests | 1 | 2013 | 200 | 0.030 |
Why?
|
| Hallucinations | 1 | 1996 | 360 | 0.030 |
Why?
|
| Personality Assessment | 1 | 1995 | 643 | 0.030 |
Why?
|
| Software | 1 | 2007 | 4434 | 0.030 |
Why?
|
| Haloperidol | 1 | 1974 | 397 | 0.030 |
Why?
|
| United States | 5 | 2017 | 69693 | 0.030 |
Why?
|
| Deinstitutionalization | 1 | 1992 | 21 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2013 | 260 | 0.030 |
Why?
|
| Face | 1 | 1998 | 993 | 0.030 |
Why?
|
| Algorithms | 1 | 2013 | 13853 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 2012 | 66 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 13921 | 0.030 |
Why?
|
| Tape Recording | 1 | 1991 | 76 | 0.030 |
Why?
|
| Electromyography | 3 | 1983 | 1391 | 0.030 |
Why?
|
| Pilot Projects | 4 | 2013 | 8297 | 0.020 |
Why?
|
| Diagnosis, Differential | 4 | 1996 | 12958 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17400 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 791 | 0.020 |
Why?
|
| Long-Term Care | 1 | 1994 | 607 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1998 | 1669 | 0.020 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 3510 | 0.020 |
Why?
|
| Comorbidity | 2 | 1996 | 10372 | 0.020 |
Why?
|
| Psychological Theory | 2 | 1983 | 168 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3528 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2016 | 62966 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 1990 | 119 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2013 | 453 | 0.020 |
Why?
|
| Eye Movements | 2 | 1983 | 506 | 0.020 |
Why?
|
| Phenelzine | 1 | 1988 | 28 | 0.020 |
Why?
|
| Antidepressive Agents | 2 | 1996 | 2838 | 0.020 |
Why?
|
| Family | 2 | 1996 | 3144 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15056 | 0.020 |
Why?
|
| Length of Stay | 2 | 1996 | 6294 | 0.020 |
Why?
|
| Imipramine | 1 | 1988 | 97 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 2 | 1982 | 149 | 0.020 |
Why?
|
| Dangerous Behavior | 1 | 1988 | 66 | 0.020 |
Why?
|
| Social Behavior | 1 | 1994 | 1128 | 0.020 |
Why?
|
| Hypertension | 1 | 2007 | 8455 | 0.020 |
Why?
|
| Dothiepin | 1 | 1986 | 2 | 0.020 |
Why?
|
| Dibenzothiepins | 1 | 1986 | 9 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2010 | 40955 | 0.020 |
Why?
|
| Risk Factors | 3 | 2012 | 72145 | 0.020 |
Why?
|
| Aged | 9 | 2006 | 162944 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2013 | 2027 | 0.020 |
Why?
|
| Arousal | 1 | 1993 | 1165 | 0.020 |
Why?
|
| Psychotherapy | 1 | 1996 | 1644 | 0.020 |
Why?
|
| Codeine | 1 | 1986 | 49 | 0.020 |
Why?
|
| Succinates | 1 | 1986 | 83 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1989 | 1309 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 2217 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 2781 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 849 | 0.020 |
Why?
|
| Dementia | 3 | 1988 | 2501 | 0.020 |
Why?
|
| Obesity | 1 | 2007 | 12705 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2372 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 1990 | 986 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 5705 | 0.010 |
Why?
|
| Sample Size | 1 | 2007 | 844 | 0.010 |
Why?
|
| Sensation | 1 | 1985 | 337 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 1940 | 0.010 |
Why?
|
| Schizophrenia, Catatonic | 1 | 1983 | 7 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4187 | 0.010 |
Why?
|
| Propiophenones | 1 | 1983 | 30 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5948 | 0.010 |
Why?
|
| Public Policy | 1 | 1988 | 572 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2012 | 1416 | 0.010 |
Why?
|
| Panic | 1 | 1983 | 106 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1987 | 518 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10578 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1984 | 635 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2699 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2572 | 0.010 |
Why?
|
| Follow-Up Studies | 5 | 1996 | 39004 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 1994 | 3391 | 0.010 |
Why?
|
| Acetaminophen | 1 | 1986 | 544 | 0.010 |
Why?
|
| Precipitating Factors | 1 | 2001 | 52 | 0.010 |
Why?
|
| Oxygen | 1 | 2013 | 4169 | 0.010 |
Why?
|
| Patient Care | 1 | 1988 | 639 | 0.010 |
Why?
|
| Child | 1 | 2010 | 77478 | 0.010 |
Why?
|
| Alcoholism | 1 | 2012 | 1904 | 0.010 |
Why?
|
| Skin Temperature | 2 | 1979 | 94 | 0.010 |
Why?
|
| Seizures | 1 | 1994 | 2851 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 2012 | 24913 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 1128 | 0.010 |
Why?
|
| Nystagmus, Pathologic | 1 | 1981 | 96 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6931 | 0.010 |
Why?
|
| Educational Status | 1 | 1988 | 2533 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 8925 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1980 | 142 | 0.010 |
Why?
|
| Phobic Disorders | 1 | 1983 | 439 | 0.010 |
Why?
|
| Relaxation Therapy | 2 | 1979 | 178 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1979 | 81 | 0.010 |
Why?
|
| Affective Symptoms | 2 | 1980 | 407 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1983 | 981 | 0.010 |
Why?
|
| Hysteria | 1 | 1978 | 22 | 0.010 |
Why?
|
| Double-Blind Method | 3 | 2007 | 12017 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1990 | 2706 | 0.010 |
Why?
|
| Patient Care Planning | 1 | 1984 | 921 | 0.010 |
Why?
|
| Social Change | 1 | 1979 | 153 | 0.010 |
Why?
|
| Movement | 2 | 1983 | 1470 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2002 | 23387 | 0.010 |
Why?
|
| Posture | 1 | 1983 | 958 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1978 | 380 | 0.010 |
Why?
|
| Cultural Characteristics | 1 | 1979 | 262 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2013 | 8541 | 0.010 |
Why?
|
| Auditory Perception | 1 | 1981 | 568 | 0.010 |
Why?
|
| Mental Processes | 1 | 1998 | 249 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 1990 | 2986 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 2714 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2011 | 3306 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1978 | 1676 | 0.010 |
Why?
|
| Butyrophenones | 1 | 1974 | 16 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7873 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1985 | 1617 | 0.010 |
Why?
|
| Public Health | 1 | 1988 | 2594 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 1997 | 975 | 0.010 |
Why?
|
| Fear | 1 | 1983 | 1436 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1988 | 7770 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 1986 | 1620 | 0.010 |
Why?
|
| Neural Inhibition | 1 | 1998 | 598 | 0.010 |
Why?
|
| Probability | 1 | 1979 | 2502 | 0.010 |
Why?
|
| Epilepsy | 1 | 1989 | 3301 | 0.010 |
Why?
|
| Life Change Events | 1 | 1978 | 937 | 0.010 |
Why?
|
| Social Environment | 1 | 1978 | 1023 | 0.010 |
Why?
|
| Cephalometry | 1 | 1995 | 382 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 53187 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15494 | 0.010 |
Why?
|
| Syndrome | 1 | 1978 | 3248 | 0.010 |
Why?
|
| Massachusetts | 1 | 1984 | 8662 | 0.010 |
Why?
|
| Lithium Carbonate | 1 | 1988 | 184 | 0.000 |
Why?
|
| Xerostomia | 1 | 1986 | 95 | 0.000 |
Why?
|
| Curriculum | 1 | 1979 | 3589 | 0.000 |
Why?
|
| Leukocyte Count | 1 | 1990 | 1583 | 0.000 |
Why?
|
| Sex Factors | 1 | 1998 | 10392 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 1978 | 3839 | 0.000 |
Why?
|
| Kidney | 1 | 1979 | 7167 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1988 | 1791 | 0.000 |
Why?
|
| Virus Diseases | 1 | 1990 | 710 | 0.000 |
Why?
|
| Nausea | 1 | 1986 | 665 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2425 | 0.000 |
Why?
|
| Anxiety | 1 | 1978 | 4279 | 0.000 |
Why?
|
| Stress, Psychological | 1 | 1978 | 4229 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1988 | 1608 | 0.000 |
Why?
|
| Constipation | 1 | 1986 | 546 | 0.000 |
Why?
|
| Prognosis | 1 | 1981 | 29010 | 0.000 |
Why?
|
| Bupropion | 1 | 1983 | 303 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1986 | 1961 | 0.000 |
Why?
|
| Depressive Disorder, Major | 1 | 1978 | 4628 | 0.000 |
Why?
|
| Kidney Concentrating Ability | 1 | 1979 | 41 | 0.000 |
Why?
|
| HIV | 1 | 1987 | 1600 | 0.000 |
Why?
|
| Animals | 1 | 2012 | 168561 | 0.000 |
Why?
|
| Masseter Muscle | 1 | 1979 | 36 | 0.000 |
Why?
|
| Blood Urea Nitrogen | 1 | 1979 | 191 | 0.000 |
Why?
|
| Saccades | 1 | 1981 | 245 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1990 | 5975 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 19862 | 0.000 |
Why?
|
| Anxiety Disorders | 1 | 1986 | 2684 | 0.000 |
Why?
|
| Creatinine | 1 | 1979 | 1916 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1979 | 2167 | 0.000 |
Why?
|
| Sleep | 1 | 1986 | 4604 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1988 | 20086 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1988 | 57683 | 0.000 |
Why?
|